An Unbiased View of Healthcare News
Novo CEO pressed by Senate to cut rates of obesity, diabetes medicine CEO Lars Fruergaard Jørgensen told lawmakers the corporation would think about new talks with insurers with regards to the record costs of Wegovy and copyright when they pledge to help keep the medicines on their own formul